My injection record
Printed from glp1injectionsites.com
Where did you
inject today?
Keep your own record of the area and the day. It stays on this device.
Choose your medicine above. The body appears here, with the areas its label names shaded.
AbdomenThigh
Back of upper arm
- Chosen, not recorded yet
- Last recorded
- Earlier record
- Area the label names
“Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm.”
No area chosen
Choose an area on the body, or by name below.
Your record
Nothing recorded yet.
Kept in this browser, on this device. We never receive your entries. On iPhone, Safari can clear a site’s saved data after seven days of using Safari without visiting that site. Adding this site to your Home Screen avoids that.
Calendar reminder, and clear my record
Calendar reminder
A repeating event for your own calendar. It does not name your medicine.
Start over
Deletes your record and settings from this browser.
What the label says about rotating
“Rotate injection sites with each dose.”
“You may inject in the same body area each week, but make sure it is not in the same spot each time.”
“lower stomach (keep 2 inches away from your belly button)”
What the Wegovy label says for your device
The label’s own words on the dose schedule, a missed dose and time out of the fridge. Open any line’s source to see where it comes from.
“0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL, or 7.2 mg/0.75 mL (WEGOVY HD) in a single-dose pen”
- Prescribing information, for the Single-dose pen
- “DOSAGE FORMS AND STRENGTHS”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
Dose schedule
“The recommended starting dosage of WEGOVY injection is 0.25 mg administered subcutaneously once weekly.”
- Prescribing information
- section 2.2
- Wegovy (semaglutide), revised 6/2026. How this label has changed
| Weeks | Once-weekly Subcutaneous Injection Dosage |
|---|---|
| 1 through 4 | 0.25 mg |
| 5 through 8 | 0.5 mg |
| 9 through 12 | 1 mg |
| 13 through 16 | 1.7 mg |
| 17 and onward | See the indication below for the recommended maintenance dosage(s) |
- Prescribing information
- section 2.2
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“If patients do not tolerate a dose during dosage escalation, consider delaying dosage escalation for 4 weeks.”
- Prescribing information
- section 2.2
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“The maintenance dosage of WEGOVY injection for cardiovascular risk reduction in adults is either 2.4 mg (recommended) or 1.7 mg once weekly.”
- Prescribing information
- section 2.2, “Cardiovascular Risk Reduction in Adults”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“The maintenance dosage of WEGOVY for weight reduction in adults is either 1.7 mg or 2.4 mg (recommended) injected subcutaneously once weekly.”
- Prescribing information
- section 2.2, “Weight Reduction in Adults”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“For patients who tolerate the 2.4 mg dosage for at least 4 weeks and additional weight reduction is clinically indicated, the dosage may be increased to a maximum dosage of 7.2 mg subcutaneously once weekly.”
- Prescribing information
- section 2.2, “Weight Reduction in Adults”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“The maintenance dosage of WEGOVY injection for weight reduction in pediatric patients aged 12 years and older is either 2.4 mg (recommended), or 1.7 mg once weekly.”
- Prescribing information
- section 2.2, “Weight Reduction in Pediatric Patients Aged 12 Years and Older”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“The recommended maintenance dosage of WEGOVY injection for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis in adults is 2.4 mg injected subcutaneously once weekly.”
- Prescribing information
- section 2.2, “Noncirrhotic MASH with Moderate to Advanced Liver Fibrosis in Adults”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“Use WEGOVY 1 time each week, on the same day each week, at any time of the day.”
- Medication Guide
- “How should I use WEGOVY?”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“If you need to change the day of the week, you may do so as long as your last dose of WEGOVY was given 2 or more days before.”
- Medication Guide
- “How should I use WEGOVY?”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
Missed dose
“If you miss a dose of WEGOVY and the next scheduled dose is more than 2 days away (48 hours), take the missed dose as soon as possible. If you miss a dose of WEGOVY and the next scheduled dose is less than 2 days away (48 hours), do not administer the dose. Take your next dose on the regularly scheduled day.”
- Medication Guide
- “How should I use WEGOVY?”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“If you miss doses of WEGOVY for 2 or more consecutive weeks, contact your healthcare provider to talk about how to restart your treatment.”
- Medication Guide
- “How should I use WEGOVY?”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
The label also gives this limit in hours. Add the time to count hours.
Counts calendar days from today, or hours and minutes when a time is added, on this device. Nothing is saved or sent.
Out of the fridge
“If needed, before removing the pen or syringe cap, WEGOVY single-dose pen and single-dose syringe can be stored from 46°F to 86°F (8°C to 30°C) in the original carton for up to 28 days.”
- Medication Guide, for the Single-dose pen and Single-dose syringe
- “How should I store WEGOVY?”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
“Throw away the WEGOVY single-dose pen or syringe if it has been frozen, has been exposed to light or temperatures above 86°F (30°C), has been out of the refrigerator for 28 days or longer, or after use.”
- Medication Guide, for the Single-dose pen and Single-dose syringe
- “How should I store WEGOVY?”
- Wegovy (semaglutide), revised 6/2026. How this label has changed
Wegovy label revised 6/2026; every line checked against it 10 Nov 2026. How these lines have changed. Quoted word for word from the label as published on DailyMed, the National Library of Medicine’s label database. DailyMed’s current label may differ from the most recent label at Drugs@FDA.
What the label says
The FDA label for Wegovy names the abdomen, the thigh and the upper arm, and says to change the injection site rather than reuse the same spot. Every line of the label about where to inject is below, quoted word for word, with a tracker set up for Wegovy.
This covers Wegovy injection. Wegovy tablets are a different product, taken by mouth, so they have no injection site. If you take Wegovy tablets, follow the tablet instructions in the Wegovy label and your prescriber. Wegovy label on DailyMed.
Every quote is checked word for word against the label on DailyMed; last checked November 10, 2026.
The Wegovy label
Wegovy (semaglutide), Novo Nordisk. Label on DailyMed, revised 6/2026.
Every line of the Wegovy label about injecting
Where to inject
“Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm.”
“You may inject into your upper leg (front of the thighs), lower stomach (keep 2 inches away from your belly button) or upper arm.”
This label lists the sites above and does not say one is less painful than another.
The upper arm
“back of upper arm (only with help from someone else).”
The belly button
“lower stomach (keep 2 inches away from your belly button)”
Changing the site
“Rotate injection sites with each dose.”
“You may inject in the same body area each week, but make sure it is not in the same spot each time.”
Skin to avoid
“Do not inject into an area where the skin is tender, bruised, red, or hard. Avoid injecting into areas with scars or stretch marks.”
With insulin
The label does not address this.
How often
“Administer WEGOVY injection once weekly, on the same day each week, at any time of day, with or without meals.”
Supply
Not on FDA’s drug shortage list (checked November 10, 2026).
Source: FDA Drug Shortages database, via openFDA. Do not rely on openFDA to make decisions regarding medical care; check with your pharmacy.
Label history
13 label versions since January 2024; 8 changed the wording this site quotes, most recently June 18, 2026. See every change.